FIGURE 4.
Incremental cost-effectiveness scatter plot of probabilistic sensitivity analysis. (A) Dabigatran vs. rivaroxaban; (B) LMWH + VKA vs. rivaroxaban.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.